{
  "retracted": false,
  "timestamp": 1467849600000,
  "updates": [
    {
      "timestamp": 1585174122531,
      "identifier": {
        "doi": "10.1038/srep28124"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/srep26428"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice"
}
